KEY DATES Application Release Date: June 2, 2025
Application Deadline: September 4, 2025 at 5:00 PM EST
Peer Review Process: September – November 2025
Applicant Notification Date: December 2025
Earliest Project Start Date: March 1, 2026
Latest Project Start Date: July 1, 2026
The Lymphoma Research Foundation maintains a strong commitment to supporting early career investigators and ensuring they can build a successful career in the field of lymphoma research. The Postdoctoral Fellowship Grant is designed to support investigators at the level of advanced fellow or postdoctoral researcher in laboratory or clinic- based research with results and conclusions that must be clearly relevant to the treatment, diagnosis or prevention of Hodgkin and/or non-Hodgkin lymphoma, including chronic lymphocytic leukemia. Areas of research may include, but are not limited to, etiology, immunology, genetics, therapies and transplantation. Historically, successful applications in this program have focused on basic, translational, and epidemiological research. The Postdoctoral Fellowship Grantee must spend 80 percent of their time in research during the award period.
The Lymphoma Research Foundation Postdoctoral Fellowship Grant provides a total of $195,000 to grantees over three years. $60,000 each year may be allocated to the PI’s salary and fringe. Incidental funds of $5,000 per year may be budgeted for research supplies or professional development expenses such as tuition, registration fees, and travel for courses and meetings. This Grant does not provide for institutional overhead.
LRF prioritizes early-career investigators through its core schemes:
Postdoctoral Fellowships: For PhD or MD holders within 2–5 years post-degree, dedicating ≥80% time to research
Clinical Investigator Career Development Awards (CDA): For clinically trained MDs within 5 years post-residency, committing ≥35–50% protected research time on clinical lymphoma research .
Lymphoma Scientific Research Mentoring Program (LSRMP): Includes a mentorship workshop and follow-up support, targeting lab and clinical juniors
Fundamental quality matters: Proposals must be hypothesis-driven, methodologically sound, and relevant to improving lymphoma diagnosis, treatment, or outcomes
CDAs must involve human subjects and clinical translational elements, not purely lab-based work .
A primary mentor (senior faculty) from your home institution is mandatory—especially for CDA and fellowships. You may add associate mentors from other institutions if relevant.
Ensure your institution demonstrates formal support and confirms protected research time.
Successful candidates typically have strong publication records, prior abstracts/grants, and demonstrated potential in lymphoma research
For CDAs and fellowships, confirm prior productivity and ability to carry out independent research.
The LSRMP offers structured mentoring and networking. Accepted scholars participate in workshops and receive professional-development grants (~$10K).
This tracks into the broader aim of building future lymphoma research leaders.
Applications are annual (e.g., 2026 cycle LOI deadline: Sept 4, 2025). No LOI required unless specified
Complete applications must include all required documents—project plan, biosketches, mentor letters, protected time statements—and be submitted via their portal.
Budgets should be realistic, covering salary support, research expenses, and development (e.g., CDAs offer 3-year salary + expenses; postdoc fellowships ~$195K total) .
Justify each cost clearly.
All proposals are assessed by LRF’s Scientific Advisory Board, a panel of ~45 lymphoma experts.
Priority is given to innovative, collaborative, and high-impact proposals.
📝 Summary Table
Predictor | What to Demonstrate |
---|---|
Career-stage alignment | Within 5 years post-degree or residency; senior mentors in place |
Scientific rigor | Hypothesis-driven, methodologically strong, and clinically relevant proposals |
Research commitment | ≥80% research time for fellowships; ≥35–50% for CDAs |
Mentor & institutional support | Strong primary mentor; protected time and resource commitment |
Track record | Publications, abstracts, previous awards |
Participation in LSRMP | Engage in mentoring program; attend workshop |
Budget justification | Realistic salary and research cost estimates |
Complete on-time application | Use portal; include all documents by deadline |
Innovation & impact | Focus on novel approaches, translational potential, and collaboration |
Choose the right grant: Postdoc Fellowship, CDA, or LSRMP.
Secure a strong mentor and confirm their time and support.
Design a clinically relevant project with clear endpoints and feasibility.
Highlight protected time and institutional commitment.
Use the mentoring program to build your network and capacity.
Budget accurately for salary, research, and training costs.
Polish all documents, especially mentor letters and biosketches.
Submit early, using deadlines as firm targets.
To account for training delays or furloughs that may have occurred as a result of the COVID-19 pandemic, the Foundation is temporarily extending the maximum eligibility for each track by one year, the new limits are noted in the section below.
1. Applicants must hold an MD, PhD, or equivalent degree. MD applicants must have completed at least two years (24 months) of their fellowship work at the start of the award period. All applicants should not have completed more than six years (72 months) of their fellowship or postdoctoral work at the start of their award period (March 1, 2026 or the start date indicated in their application budget).
2. Individuals who currently or have previously held faculty positions prior to the start date stated in their application budget are not eligible to apply; awarded applicants may move into faculty positions during the award period.
3. Applicants must be affiliated with a sponsoring academic or nonprofit research institution in the U.S. or Canada, be legal to work in either country for the duration of the Lymphoma Research Foundation Grant and intend to pursue a career in lymphoma research. Applicants based at the NIH or another U.S. government entity are not eligible to apply for Postdoctoral Fellowship Grants. Citizenship or permanent residency is not required for general Fellowship Grant eligibility but may affect eligibility for Health Equity Initiative funds.
4. Applicant must secure a primary sponsor at their home institution who will supervise the proposed research project. The sponsor’s role is to assure (on behalf of the Institution) that the specific aims of the project are met and to present the Institution’s role in the development of the applicant’s career. The primary sponsor may support only one applicant to the Lymphoma Research Foundation Postdoctoral Fellowship Grant per grant cycle. Up to four associate sponsors (including at other institutions) are permitted but not required.
5. Applications are encouraged from qualified individuals without regard to age, race, religion, sex, creed, national origin or any other characteristics protected by law.
6. During the award period, the Grantee must spend a minimum of 80 percent of his/her time in research without major patient care, teaching, or administrative responsibilities except as such responsibilities relate directly to a pre-clinical or clinical lymphoma research project.
7. The Postdoctoral Fellowship Grantee may not hold another competitively applied for fellowship and/or a grant that primarily supports Principal Investigator (PI) salary during the period of the Lymphoma Research Foundation Grant, except if awarded as part of an NIH Institutional Training Grant (T32/K12 or equivalent). Supply and material costs for the clinical research project should be supported by another grant or from institutional funds. The percent of research time for the PI on all active grants should not add up to more than 100%. The Foundation must be informed as to the sources and the amounts of all extramural/noninstitutional funding received by the Fellowship recipient during the term of the Lymphoma Research Foundation Grant, and reserves the right to determine that the Grant may not be held concurrent with other funding.
8. A previous Lymphoma Research Foundation Postdoctoral Fellowship Grant recipient cannot apply for another Postdoctoral Fellowship Grant other than in exceptional circumstances, which is decided on a case-by-case basis. However, applicants from previous years who did not receive an award are welcome to apply if they still meet eligibility requirements – please see the section on resubmissions in the Research Proposal section on page 6.
9. All Lymphoma Research Foundation applications are self-initiated. The Foundation does not invite applications from selected individuals or laboratories.
Eligible Countries:
Sponsor Institute/Organizations: Lymphoma Research Foundation
Sponsor Type: Corporate/Non-Profit
Address: Wall Street Plaza, 88 Pine St Suite 2400, New York, NY 10005, United States
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 04, 2025
$195,000
Affiliation: Lymphoma Research Foundation
Address: Wall Street Plaza, 88 Pine St Suite 2400, New York, NY 10005, United States
Website URL: https://lymphoma.org/wp-content/uploads/2025/05/FY2026-Fellowship-RFP.pdf
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.